MarketsStocksLYKALABS
LY

Lyka Labs Ltd

NSE: LYKALABSBSE: 500259Healthcare
60.36
+4.99%
NSE · 15-min delayed
Prev Close
₹116.92
Day High
₹60.36
Day Low
₹54.65
Mkt Cap
₹208 Cr
P / E
26.3
P / B
2.3
ROE
-11.3%
52W High
₹125.50
52W Low
₹44.10
Key Metrics
Market Cap
₹208 Cr
P / E
26.3
P / B
2.3
ROCE
-6.1%
ROE
-11.3%
Div Yield
-
Revenue · ₹ Cr
61
FY20
86
FY21
194
FY22
93
FY23
111
FY24
138
FY25
128
FY26
Net Profit · ₹ Cr
-63
FY20
-12
FY21
39
FY22
-13
FY23
-3
FY24
8
FY25
-10
FY26
EPS · ₹ per share
₹-1.8
FY19
₹-27.3
FY20
₹-4.1
FY21
₹13.6
FY22
₹-4.6
FY23
₹-0.8
FY24
₹2.2
FY25
P / E Ratio · price ÷ TTM EPS
0359718107771421Jun 21Dec 22Aug 24Jun 26
P/E 958.2×Median 17.8×TTM EPS
Q1 2026 snapshot
Sales
₹29 Cr
Operating profit
-
OPM
-
Net profit
₹-8 Cr
EPS
₹-2.13
Scorecard · 7 axes
Quality
Bad
28/100
Valuation
Avg
26.3×
Growth
Bad
-22.8%
Profitability
Bad
-8.7%
Performance
Bad
-48.4%
Entry Point
Strong
48%
Red Flags
Strong
0 flags
Shareholding Pattern
58.2%Promoter
Promoter58.2%
FII0.3%
DII0.7%
Public40.9%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue33.79833.4333.6637.7531.8928.64
Net Profit2.7042.030.996-3.214-0.151-8.066
NPM %8.0%6.1%3.0%-8.5%-0.5%-28.2%
AlertPre-trade